Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

TeleHealth Weight Solutions review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

The first charge here is two months, not one: "Semaglutide: $650 ($325 per month), Tirzepatide: $750 ($375 per month)", with a reassessment at six weeks. After that the model changes entirely — maintenance is sold by the vial, 1ML to 5ML, and the site's "as low as $60 per month" figure describes a vial that "may last up to one year", so it is a year bought at once. A team of board-certified nurse practitioners runs it, and it has a high entry price.

$325/mo, charged as $650 up front

Consult Medication
See plans at TeleHealth Weight Solutions
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

TeleHealth Weight Solutions at a glance

Semaglutide
$325/mo, charged as $650 up front
Tirzepatide
$375/mo, charged as $750 up front
Coverage
Not published on the site
Brand-name
Compounded only

How we scored TeleHealth Weight Solutions

Every factor comes from TeleHealth Weight Solutions's own published pricing, disclosures and oversight, and the six combine into the 40/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

True monthly cost34/100 · Weak

Cost is unpredictable or sits at the premium end.

Postpartum & breastfeeding guidance30/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit30/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Ongoing support58/100 · Weak

Support is thin once the prescription ships.

Clinical oversight & labs54/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

Cancellation fairness34/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

The first charge is a two-month block: "Semaglutide: $650 ($325 per month)" and "Tirzepatide: $750 ($375 per month)", with a reassessment at six weeks. Maintenance is then sold by the vial in sizes from 1ML to 5ML, and the site's "as low as $60 per month" describes a vial that "may last up to one year" — a year's supply bought at once, with the vial prices themselves unpublished. A one-time $125 fee applies to transferring patients. The practice is run by board-certified nurse practitioners, publishes no list of states, and serves its software vendor's privacy policy in place of its own.

Pricing

MedicationPricePlan
Compounded semaglutide$325Initial block, two months"Initial Cost: Semaglutide: $650 ($325 per month)" — charged as one $650 payment, with a reassessment at six weeks.
Compounded tirzepatide$375Initial block, two months"Tirzepatide: $750 ($375 per month)", on the same terms.
Compounded semaglutide$60Maintenance, by the vial"Larger vials may last up to one year, with costs as low as $60 per month." That is a year's supply bought at once; individual vial prices are not published.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what TeleHealth Weight Solutions's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • States the total and the per-month figure together — "$650 ($325 per month)" — rather than quoting only the smaller one
  • A reassessment is built into the schedule at six weeks, with the dose adjusted then
  • Run by a named team of board-certified nurse practitioners rather than an anonymous provider network
  • Maintenance pricing genuinely falls once you are stable, and the vial sizes are published
  • The one-time transferring-patient fee of $125 is disclosed with a figure

The caveats

  • The entry price is the highest in this group and is charged as a two-month block: $650 or $750 before anything else
  • The "as low as $60 per month" maintenance figure requires a vial that "may last up to one year", so it is a year's supply bought in a single payment
  • Vial pricing is not published — the site says to contact them for it
  • Its privacy policy is not its own: the page serves SimplePractice's policy, its practice-management vendor, verbatim and dated September 2022
  • No list of states served is published
  • The initial block works out to two months at the stated monthly rate, but the reassessment is at six weeks, so the two do not line up

Budget for the initial payment, not the divided figure

TeleHealth Weight Solutions advertises an initial $650 payment for semaglutide and $750 for tirzepatide, alongside monthly equivalents of $325 and $375. Those smaller numbers are not separate monthly charges. Someone deciding whether to begin needs to be comfortable with the whole initial payment, rather than assuming that the first prescription can be purchased for half that amount.

The schedule also calls for reassessment after six weeks. The quoted totals divide into two months at the stated equivalents, so the payment description and clinical review date do not establish one clear supply period. Ask how much medication is dispensed, how long that quantity is intended to last and whether another payment can be due before the reassessment.

Maintenance pricing is not a published monthly plan

The service says medication is available by the vial, with sizes from 1 mL to 5 mL, and that larger vials may last up to a year. Its claim of costs as low as $60 per month depends on that longer supply. It should not be read as a monthly prescription offer available to every continuing patient.

Individual vial prices are not published in its published information. A maintenance quote therefore needs both the vial total and the prescribed quantity, not just an estimate divided across many months. Ask the dispensing pharmacy about the product’s storage and use instructions; a marketing statement about how long a vial may last is not a substitute for those directions.

Transferring patients face a separate fee

A $125 one-time transferring-patient office fee is disclosed in addition to the vial cost. Someone moving from another service should include that amount when comparing the first order, rather than treating maintenance pricing as the entire switching cost. The fee and the medication purchase answer different parts of the budget.

The practice describes itself as a team of board-certified nurse practitioners. That is the seller’s professional description, rather than a reason to assume a specific clinician’s certification without checking who will provide care. Ask which practitioner handles the assessment and follow-up, whether a live appointment is included and how the six-week review affects further prescribing.

The portal vendor is not the practice

The public privacy page presents SimplePractice’s client-portal privacy policy. SimplePractice is the software vendor described in that document, not an established operating entity for TeleHealth Weight Solutions. A patient should distinguish the company providing the portal from the medical practice responsible for treatment, records and patient communications.

The published contact address is in Herndon, Virginia, but the public material does not list service states or establish a complete operating-company identity. Confirm that the treating practitioner can serve the intended state and ask for the practice’s own privacy and treatment agreements. A working portal and a mailing address do not settle those questions on their own.

The useful fit is a carefully quoted continuing relationship

The six-week reassessment may appeal to someone who wants a scheduled opportunity to discuss progress and prescription changes. Its value depends on the actual contact provided, not just the presence of a date on the program page. Establish how to reach the clinical team before that appointment if a medication question arises.

TeleHealth Weight Solutions deserves a prescription-specific discussion before any price comparison. The initial block, transfer fee and undisclosed vial prices make a headline monthly equivalent insufficient. A reader comfortable with upfront purchases may find the model workable, but should first resolve supply duration, clinical access, state eligibility and the terms governing medication already paid for. The $60 maintenance advertisement cannot answer those questions.

The bottom line for mothers

Best for: Someone who can pay two months up front and wants nurse-practitioner-led care rather than an app.

Alternatives to TeleHealth Weight Solutions

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Compounded semaglutide at $59 per month and tirzepatide at $69, with a separate required $199 annual membership. Twelve medication charges plus membership total $907 or $1,027 in the first year. A 21-day membership trial precedes the annual charge; it does not promise free medication, and paid membership fees are non-refundable. The program lists 44 states, excluding Alabama, California, Louisiana, Massachusetts, Mississippi and Washington. Confirm the dispensing pharmacy and the cancellation deadlines before joining.

    Visit Collective
  • A $99 first month for either injection, with the ongoing price shown only at checkout, and a real non-injection option most providers we review skip: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.

    Visit SkinnyRx

Providers like TeleHealth Weight Solutions

Keep comparing TeleHealth Weight Solutions

TeleHealth Weight Solutions, answered

How much does TeleHealth Weight Solutions cost?
TeleHealth Weight Solutions does not establish a comparable recurring monthly medication rate. Published pricing: $325/mo, charged as $650 up front for semaglutide; $375/mo, charged as $750 up front for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
Is TeleHealth Weight Solutions safe to use while breastfeeding?
No GLP-1 is established as safe in pregnancy. If you are nursing, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels say there is little or no data on the drug in breast milk, and they leave it to you and your clinician to weigh the benefits of breastfeeding against your need for treatment. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. TeleHealth Weight Solutions is not an exception to any of that — settle the timing with your own clinician.
Does TeleHealth Weight Solutions offer both semaglutide and tirzepatide?
Yes — TeleHealth Weight Solutions offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does TeleHealth Weight Solutions score for mothers?
TeleHealth Weight Solutions scores 40/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect TeleHealth Weight Solutions's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers